Clinical Research


Clinical TrialsClinical Research

Clinical Trials

Kansas Institute of Research Focused on Safety and Quality Care

 

The clinical research team at Kansas Institute of Research has been conducting clinical trials for several years. Recently a group dedicated to increased quality and focus was created. Under the direction of Atul T. Patel, M.D., a physical medicine and rehabilitation physician, the team and support staff brings more than 27 years of combined research experience.

 

Along with their commitment to quality research, team members emphasize compassion and dedication to patient care. As a focused group, they have been able to target the common goal and are poised to launch more studies.

 

The idea of locating this research at the physician’s location provides Dr. Patel and his team valuable proximity for research. The clinic improves accessibility for close monitoring of patients and ensures the safety and care of all patients.

 

As a physical medicine and rehabilitation specialist, Dr. Patel treats conditions involving the muscles (weakness, muscular dystrophy), bones and joints (arthritis and sprains), nerves (neuropathy and pain), brain and spinal cord (stroke, Parkinson’s disease, multiple sclerosis, cerebral palsy). He uses special tests and equipment (electromyography and nerve condition studies – EMGs and ultrasound) to help with the diagnosis of some of these conditions.

 

His treatment focus is to improve patients’ function. The research team has conducted several clinical studies in areas that include post-stroke spasticity, nerve pain as a result of trauma or surgery and cervical dystonia.

 

The research group is currently examining new studies and growth potential. While these opportunities present exciting changes, their commitment to the initial goal of patient safety and care remains unchanged.

 

 

Current clinical trials Kansas Institute of Research is involved in.

 

Migraine Headache- Are you between the age of 18 and 65?  Do you have a Migraine headache?

Potential patients must:

  • Having 15 or more days per month with headaches lasting 4 hours a day or more.
  • Has never taken any treatment with Topiramate (Topamax) or Botox.

 

Upper and Lower Limb Spacticity- Are you between the age of 18 and 80?  Is your most recent stroke occurring at least three months ago?  Do you have muscle tightness in the arms?

 

Post-Stroke Stem Cell– Are you between the age of 18 to 80? Are you between 6 and 60 months post- stroke? Is your neurological motor function substantially affected due to stroke?

 

 

Qualified participants receive study‐related exams, lab tests, and study medication at no cost. Compensation may be provided for time and travel. No overnight stays required.

Is clinical trial for you?

Who should consider clinical trials and why?

It is important to test drugs and medical products in the people they are meant to help. It is also important to conduct research in a variety of people because different people may respond differently to treatments. FDA seeks to ensure that people of different ages, races, ethnic groups, and genders are included in clinical trials.

 

Some people participate in clinical trials because they have exhausted standard (approved) treatment options – which either did not work for them, or they were unable to tolerate certain side effects. Clinical trials may provide another option when standard therapy has failed.

 

Other people participate in trials because they want to contribute to the advancement of medical knowledge.

 

For each clinical trial, researchers develop eligibility criteria, such as the age, sex, type and stage of disease, previous treatment history, and other medical conditions. These criteria help to reduce the amount of variation in the study, without threatening the scientific integrity of the trial, by removing medical variations that might complicate analyzing the results.

 

Not everyone who applies for a clinical trial will be accepted. Volunteers may be excluded based on the eligibility criteria and/or the number of participants needed by the researchers to collect enough information to determine the safety and effectiveness of a therapeutic agent.